MP753PHARMACOECONOMIC ASSESSMENT OF PATIENTS SWITCHING FROM SUCROFERRIC OXHYDROXIDE TO SEVELAMER CARBONATE IN PATIENTS ON HEMODIALYSIS IN SEVEN EUROPE COUNTRIES | Zendy

AI Assistant Blog Pricing

MP753PHARMACOECONOMIC ASSESSMENT OF PATIENTS SWITCHING FROM SUCROFERRIC OXHYDROXIDE TO SEVELAMER CARBONATE IN PATIENTS ON HEMODIALYSIS IN SEVEN EUROPE COUNTRIES

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.